Laboratory Science & Tools Medical Devices & Diagnostics

Beckman Coulter Life Sciences and Automata partner on AI-ready laboratory automation

AI-ready laboratory automation robotic workstations processing samples
  • Beckman Coulter Life Sciences and Automata announced a laboratory automation partnership.

  • The collaboration integrates lab instruments with Automata’s LINQ robotics platform.

  • The goal is to support AI-ready laboratory automation and scalable research workflows.

  • Danaher Ventures will invest in Automata as part of the partnership.

Beckman Coulter Life Sciences and Automata have announced a partnership focused on AI-ready laboratory automation. The collaboration integrates Beckman Coulter instruments with Automata’s automation platform to help research laboratories automate workflows and scale scientific experimentation.

AI-ready laboratory automation partnership announced

Beckman Coulter Life Sciences and London-based automation company Automata are working together to integrate liquid handling, genomic and cell analysis technologies with Automata’s LINQ automation ecosystem.

The collaboration combines laboratory instruments with robotics, workflow orchestration software and modular automation systems designed to support large-scale research operations.

How AI-ready laboratory automation is transforming research

AI-ready laboratory automation platforms aim to standardise complex experimental workflows while producing structured datasets suitable for machine learning analysis. By combining robotics, connected instruments and cloud-based software, laboratories can automate multi-step experimental processes.

These systems are increasingly used to support drug discovery, genomics research and high-throughput screening studies where consistent data generation is critical.

Integration with Automata’s LINQ automation ecosystem

The partnership integrates Beckman Coulter Life Sciences instruments into Automata’s LINQ platform, which provides modular robotics and scheduling software to manage laboratory workflows.

The system is designed to allow laboratories to configure modular work cells that can be expanded or adapted for different experimental applications.

Investment supports long-term collaboration

The collaboration also includes an investment by Danaher Ventures, which will participate in Automata’s Series C funding round and join the company’s board of directors.

According to the companies, the partnership aims to enable research organisations to generate more reliable data, increase workflow efficiency and support AI-driven scientific discovery.

Further developments in laboratory technologies can be found in the Laboratory Science & Tools section of Life Sciences Global News.